Strengthening Medical Product Regulation in Low- and Middle-Income Countries
Authors:
- Charles PrestonCPCharles Preston
- Mary Lou ValdezMVMary Lou Valdez
- Katherine BondKBKatherine Bond
Open Access
- 23 October 2012
- journal article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 9 (10) , e1001327
Abstract
Charles Preston and colleagues use case studies to describe how regulatory systems for medical products and medicines must be strengthened in low and middle income countries to assure adequate quality, safety and efficacy.Keywords
This publication has 8 references indexed in Scilit:
- The make or buy debate: Considering the limitations of domestic production in TanzaniaGlobalization and Health, 2012
- As Production Goes Global, Drug Supply Faces Greater Risks to Safety, Quality2011
- Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting PrioritiesPLOS Medicine, 2011
- Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For AfricaHealth Affairs, 2011
- Health-systems strengthening: current and future activitiesThe Lancet, 2011
- Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment ProgramsJAMA, 2010
- Regulatory oversight of clinical trials in Africa: Progress over the past 5 yearsVaccine, 2009
- India's growing clinical research sector: opportunity for global companies.2007